Why This Analyst Is Awaiting More Efficacy Signals For Agios Pharma Candidates

By: via Benzinga
BTIG analyst Ling Wang initiated coverage on Agios Pharmaceuticals Inc (NASDAQ: AGIO) shares with a Neutral rating, citing balanced ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.